Free tool
Drug literature search
Last checked: Nov 20, 2026Source: PubMed, Europe PMC, OpenAlex
1,606 results in PubMed
Peer-reviewed biomedical literature from the US National Library of Medicine, most relevant first. Showing the first 25. Limited to clinical trials, meta-analyses and systematic reviews.
- Prevalence and Incidence of Huntington's Disease: An Updated Systematic Review and Meta-Analysis.
Medina A, Mahjoub Y, Shaver L, et al. · Mov Disord · 2022Meta-Analysis, Systematic Review
- The reliability and validity of the Timed Up and Go as a clinical tool in individuals with and without disabilities across a lifespan: a systematic review.
Christopher A, Kraft E, Olenick H, et al. · Disabil Rehabil · 2021Systematic Review
- Physical Therapy and Exercise Interventions in Huntington's Disease: A Mixed Methods Systematic Review.
Fritz NE, Rao AK, Kegelmeyer D, et al. · J Huntingtons Dis · 2017Systematic Review
- Scale for the assessment and rating of ataxia: development of a new clinical scale.
Schmitz-Hübsch T, du Montcel ST, Baliko L, et al. · Neurology · 2006Randomized Controlled Trial, Research Support, Non-U.S. Gov't
- Targeting Huntingtin Expression in Patients with Huntington's Disease.
Tabrizi SJ, Leavitt BR, Landwehrmeyer GB, et al. · N Engl J Med · 2019Clinical Trial, Phase I, Clinical Trial, Phase II
- Structural and functional neuroplasticity in music and dance-based rehabilitation: a systematic review.
Blasi V, Rapisarda L, Cacciatore DM, et al. · J Neurol · 2025Systematic Review
- Pridopidine in early-stage manifest Huntington's disease: a phase 3 trial.
Reilmann R, Feigin A, Rosser AE, et al. · Nat Med · 2025Clinical Trial, Phase III, Randomized Controlled Trial
- Anxiety in Huntington's Disease.
Dale M, van Duijn E · J Neuropsychiatry Clin Neurosci · 2015Systematic Review
- Systematic Review with Meta-Analysis of Biofluid Markers for Huntington's Disease.
Paulsen JS, Bovin NA, Clemsen JD, et al. · Mov Disord · 2025Meta-Analysis, Systematic Review
- The pharmacodynamics-based prophylactic benefits of GLP-1 receptor agonists and SGLT2 inhibitors on neurodegenerative diseases: evidence from a network meta-analysis.
Tseng PT, Zeng BY, Hsu CW, et al. · BMC Med · 2025Systematic Review, Network Meta-Analysis
- Pharmacokinetics and pharmacodynamics of PTC518, an oral huntingtin lowering splicing modifier: A first-in-human study.
Gao L, Bhattacharyya A, Beers B, et al. · Br J Clin Pharmacol · 2024Randomized Controlled Trial, Clinical Trial, Phase I
- Clozapine in Huntington's chorea.
Bonuccelli U, Ceravolo R, Maremmani C, et al. · Neurology · 1994Clinical Trial
- Safety and efficacy of valbenazine for the treatment of chorea associated with Huntington's disease (KINECT-HD): a phase 3, randomised, double-blind, placebo-controlled trial.
Furr Stimming E, Claassen DO, Kayson E, et al. · Lancet Neurol · 2023Randomized Controlled Trial, Clinical Trial, Phase III
- Transcranial magnetic stimulation neurophysiology in patients with non-Alzheimer's neurodegenerative diseases: A systematic review and meta-analysis.
Mimura Y, Tobari Y, Nakahara K, et al. · Neurosci Biobehav Rev · 2023Meta-Analysis, Systematic Review
- The Safety of Deutetrabenazine for Chorea in Huntington Disease: An Open-Label Extension Study.
Frank S, Testa C, Edmondson MC, et al. · CNS Drugs · 2022Multicenter Study, Randomized Controlled Trial
- Huntington's disease prevalence in Asia: a systematic review and meta-analysis.
Papanna B, Lazzari C, Rabottini M · Riv Psichiatr · 2024Meta-Analysis, Systematic Review
- A systematic review and meta-analysis of depression and apathy frequency in adult-onset Huntington's disease.
Clark ML, Abimanyi-Ochom J, Le H, et al. · Neurosci Biobehav Rev · 2023Meta-Analysis, Systematic Review
- Epidemiology of Huntington's Disease in Latin America: A Systematic Review and Meta-Analysis.
Medina Escobar A, Pringsheim T, Gautreau S, et al. · Mov Disord · 2024Systematic Review, Meta-Analysis
- Trk receptor alterations in Alzheimer's disease.
Connor B, Young D, Lawlor P, et al. · Brain Res Mol Brain Res · 1996Clinical Trial, Controlled Clinical Trial
- [Dance therapy in the rehabilitation of neurological diseases].
Sivertseva SA, Anfilofeva KS, Zotova AV, et al. · Zh Nevrol Psikhiatr Im S S Korsakova · 2022Meta-Analysis, Systematic Review
- Apathy and Huntington's Disease: A Literature Review Based on PRISMA.
Matmati J, Verny C, Allain P · J Neuropsychiatry Clin Neurosci · 2022Systematic Review
- Huntington's disease in MENAT: systematic review and meta-analysis of prevalence, clinical features, and genetics.
Alshimemeri S, Shadid AM, Aldraihem O, et al. · J Neurol · 2025Systematic Review, Meta-Analysis
- An orally available, brain penetrant, small molecule lowers huntingtin levels by enhancing pseudoexon inclusion.
Keller CG, Shin Y, Monteys AM, et al. · Nat Commun · 2022Clinical Trial, Phase II, Clinical Trial, Phase I
- Sexual dysfunction in Huntington's Disease: what do we really know?
Tipton PW · Neurol Neurochir Pol · 2020Systematic Review
- Sleep in Huntington's disease: a systematic review and meta-analysis of polysomongraphic findings.
Zhang Y, Ren R, Yang L, et al. · Sleep · 2019Meta-Analysis, Research Support, N.I.H., Extramural
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.